Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The safety profile of Polyoxidonium in daily practice: results from postauthorization safety study in Slovakia.

Pružinec P, Chirun N, Sveikata A.

Immunotherapy. 2018 Feb;10(2):131-137. doi: 10.2217/imt-2017-0116.

PMID:
29260620
2.

Comparison of the pharmacokinetic and pharmacodynamic properties of two recombinant granulocyte colony-stimulating factor formulations after single subcutaneous administration to healthy volunteers.

Sveikata A, Gumbrevičius G, Seštakauskas K, Kregždytė R, Janulionis V, Fokas V.

Medicina (Kaunas). 2014;50(3):144-9. doi: 10.1016/j.medici.2014.08.001. Epub 2014 Aug 13.

3.

Paracetamol and simvastatin: a potential interaction resulting in hepatotoxicity.

Gumbrevičius G, Sveikata A, Sveikatienė R, Stankevičius E.

Medicina (Kaunas). 2012;48(7):379-81.

4.

The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania.

Valantinas J, Apanaviciene DA, Maroziene L, Sveikata A.

Med Sci Monit. 2012 May;18(5):PH57-62.

5.

An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients.

Sveikata A, Liutkauskienė S, Juozaitytė E, Characiejus D, Tamošaitytė L, Šeštakauskas K.

Medicina (Kaunas). 2011;47(8):428-33. Epub 2011 Nov 18.

6.

Rationality of administered gentamicin dose in cerebral coma patients treated in an intensive care unit.

Janušonis T, Mačiulaitis R, Sveikata A, Milašius A, Kregždytė R.

Medicina (Kaunas). 2011;47(2):79-84. English, Lithuanian.

7.

Severe vancomycin-induced anaphylactic reaction.

Kupstaite R, Baranauskaite A, Pileckyte M, Sveikata A, Kadusevicius E, Muckiene G.

Medicina (Kaunas). 2010;46(1):30-3.

8.

Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.

Danileviciūte V, Sveikata A, Adomaitiene V, Gumbrevicius G, Fokas V, Sveikatiene R.

Medicina (Kaunas). 2009;45(10):778-84.

9.
10.

Characteristics of gender-related circadian arterial blood pressure in healthy adolescents.

Driziene Z, Jakutiene E, Stakisaitis D, Pundziene B, Sveikata A.

Medicina (Kaunas). 2008;44(10):768-74.

11.

Analysis of antidepressant prescribing tendencies in Lithuania in 2003-2004.

Jakimavicius M, Sveikata A, Vainauskas P, Jankūnas R, Mikucionyte L, Sapoliene A, Smigelskas K.

Medicina (Kaunas). 2007;43(5):412-8.

12.

Trends in the consumption of antidepressant drugs in Lithuania in 2002-2004.

Kadusevicius E, Mikucionyte L, Maciulaitis R, Milvidaite I, Sveikata A.

Medicina (Kaunas). 2006;42(12):1020-9.

13.

[Compliance in psychiatry: results of a survey of depressed patients using orally disintegrating tablet].

Danileviciūte V, Adomaitiene V, Sveikata A, Maciulaitis R, Kadusevicius E, Volbekas V.

Medicina (Kaunas). 2006;42(12):1006-12. Lithuanian.

14.

[A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine].

Gumbrevicius G, Sveikata A.

Medicina (Kaunas). 2006;42(8):649-52. Lithuanian.

15.

[Nonsteroidal anti-inflammatory agents--choice between disturbances of gastrointestinal tract and cardiovascular toxicity].

Gumbrevicius G, Milasius A, Sveikata A.

Medicina (Kaunas). 2006;42(5):429-39. Review. Lithuanian.

16.

[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].

Kazlauskas S, Kontrimaviciūte V, Sveikata A.

Medicina (Kaunas). 2004;40(3):216-9. Review. Lithuanian.

17.

[Present-day approach to pharmacological and clinical aspects of novel antidepressants].

Danileviciūte V, Sveikata A.

Medicina (Kaunas). 2002;38(12):1147-56. Review. Lithuanian.

18.

[Antipsychotic agents and pharmacotherapy of psychoses].

Jankūnas R, Sveikata A, Milasius A.

Medicina (Kaunas). 2002;38(4):471-7; quiz 478. Lithuanian.

Supplemental Content

Loading ...
Support Center